Finally, feeding flies with trametinib, a small compound inhibitor of MEK, significantly ameliorated TDP-43-induced behavioral deficits in fly models, offering an opportunity for developing new therapeutic strategies aimed at the intervention of ALS and other TDP-43-related diseases. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.